Literature DB >> 3683484

Prognostic importance of thallium uptake by the lungs during exercise in coronary artery disease.

J B Gill1, T D Ruddy, J B Newell, D M Finkelstein, H W Strauss, C A Boucher.   

Abstract

We studied the value of thallium imaging as compared with clinical and exercise-test variables in predicting cardiac events occurring over five years in 525 consecutive patients referred for thallium-exercise testing in 1979. Follow-up was obtained on 467 patients (89 percent). There were 105 cardiac events--25 cardiac deaths, 33 myocardial infarctions, and 47 coronary bypass procedures. A Cox survival analysis identified increased thallium uptake by the lungs, a marker of left ventricular dysfunction during exercise, as the best predictor of a cardiac event (relative risk ratio = 3.5; 95 percent confidence interval, 2.2 to 5.4). The next most powerful predictors were a history of typical angina, a previous myocardial infarction, and ST-segment depression during exercise (relative risk ratios = 2.1, 1.8, and 1.7, respectively). No combination of variables made up for the loss in prognostic power when the variable of increased thallium uptake by the lungs was removed from the model. Cardiac events occurred over five years in 10 (5 percent) of 192 patients with a normal thallium scan, 41 (25 percent) of 163 patients with an abnormal thallium scan but normal thallium activity in the lungs, and 54 (67 percent) of 81 patients with increased thallium uptake by the lungs (P less than 0.0001). We conclude that increased uptake of thallium by the lungs during exercise predicts a high risk of subsequent cardiac events.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3683484     DOI: 10.1056/nejm198712103172401

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  46 in total

1.  Effects of smoking on pulmonary uptake of technetium-99m methoxyisobutylisonitrile during myocardial perfusion imaging.

Authors:  C H Kao; Y Y Shen; J K Lee
Journal:  J Nucl Cardiol       Date:  1999 Jan-Feb       Impact factor: 5.952

Review 2.  Comparison of Tl-201 with Tc-99m-labeled myocardial perfusion agents: technical, physiologic, and clinical issues.

Authors:  P Kailasnath; A J Sinusas
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

3.  Diagnostic value of Tl-201 lung uptake is dependent on measurement method.

Authors:  A Hitzel; A Manrique; A Cribier; P Véra
Journal:  J Nucl Cardiol       Date:  2001 May-Jun       Impact factor: 5.952

4.  Comparison of two three-dimensional gated SPECT methods with thallium in patients with large myocardial infarction.

Authors:  P Véra; R Koning; A Cribier; A Manrique
Journal:  J Nucl Cardiol       Date:  2000 Jul-Aug       Impact factor: 5.952

Review 5.  Transient ischemic dilation: a powerful diagnostic and prognostic finding of stress myocardial perfusion imaging.

Authors:  Michael G McLaughlin; Peter G Danias
Journal:  J Nucl Cardiol       Date:  2002 Nov-Dec       Impact factor: 5.952

6.  The cavity-to-myocardial count ratio as a marker of left ventricular function.

Authors:  Jeroen J Bax; Hildo J Lamb; Ernst E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2002-10       Impact factor: 2.357

7.  Increased lung uptake on exercise Tl-201 SPECT may reflect more than extent of myocardial ischemia.

Authors:  Jabour Khoury; Jacqueline Jerushalmi; Norman Loberant; Nathan Roguin; Marc Brezins
Journal:  J Nucl Cardiol       Date:  2003 Jul-Aug       Impact factor: 5.952

Review 8.  The use of thallium-201 lung/heart ratios.

Authors:  S Mahmood; J R Buscombe; P J Ell
Journal:  Eur J Nucl Med       Date:  1992

Review 9.  Assessment of prognosis in chronic coronary artery disease.

Authors:  T M Bateman; E Prvulovich
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

10.  Long-term prognostic value of early poststress (99m)Tc-tetrofosmin lung uptake during exercise (SPECT) myocardial perfusion imaging.

Authors:  Panagiotis Georgoulias; Ioannis Tsougos; Varvara Valotassiou; Chara Tzavara; Petros Xaplanteris; Nikolaos Demakopoulos
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12-17       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.